Jonathon Unwin
Stock Analyst at Barclays
(0.23)
# 4,539
Out of 4,966 analysts
63
Total ratings
27.3%
Success rate
-15.3%
Average return
Main Sectors:
Stocks Rated by Jonathon Unwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: ONT Oxford Nanopore Technologies plc | Reiterated: Buy | 182p | 157p | +16.00% | 9 | Sep 8, 2026 | |
| SWX: YPSN Ypsomed Holding AG | Reiterated: Buy | CHF 386.00 → CHF 480.00 | CHF 354.00 | +35.59% | 7 | Aug 18, 2026 | |
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Upgraded: Buy | €16.00 → €27.00 | €23.25 | +16.13% | 13 | Aug 18, 2026 | |
| ETR: AFX Carl Zeiss Meditec AG | Reiterated: Hold | €28.00 → €27.00 | €30.30 | -10.89% | 11 | Aug 11, 2026 | |
| ETR: GXI Gerresheimer AG | Reiterated: Sell | €17.00 → €25.00 | €28.22 | -11.41% | 9 | Jul 29, 2026 | |
| STO: VIMIAN Vimian Group AB (publ) | Reiterated: Sell | kr 26.00 → kr 29.00 | kr 34.15 | -15.08% | 14 | Jul 23, 2026 |
Oxford Nanopore Technologies plc
Sep 8, 2026
Reiterated: Buy
Price Target: 182p
Current: 157p
Upside: +16.00%
Ypsomed Holding AG
Aug 18, 2026
Reiterated: Buy
Price Target: CHF 386.00 → CHF 480.00
Current: CHF 354.00
Upside: +35.59%
SCHOTT Pharma AG & Co. KGaA
Aug 18, 2026
Upgraded: Buy
Price Target: €16.00 → €27.00
Current: €23.25
Upside: +16.13%
Carl Zeiss Meditec AG
Aug 11, 2026
Reiterated: Hold
Price Target: €28.00 → €27.00
Current: €30.30
Upside: -10.89%
Gerresheimer AG
Jul 29, 2026
Reiterated: Sell
Price Target: €17.00 → €25.00
Current: €28.22
Upside: -11.41%
Vimian Group AB (publ)
Jul 23, 2026
Reiterated: Sell
Price Target: kr 26.00 → kr 29.00
Current: kr 34.15
Upside: -15.08%